Literature DB >> 12509768

Screening for lung cancer: in pursuit of pre-metastatic disease.

James L Mulshine1.   

Abstract

One reason for the high death rate of lung cancer is that tumours are not usually detected until the disease is at a late stage, at which point the cancer is non-curable. Spiral computerized tomography is a highly sensitive imaging method that could be used to screen high-risk populations, such as current or former smokers, for early-stage tumours. Trials to validate this tool are just underway, but beyond the imaging tools, population-based care of pre-metastatic lung cancer requires considerable evolution in clinical management approaches. More sensitive imaging tools might also provide a window into earlier biology, enabling the molecular dynamics of lung cancer progression to be elucidated.

Entities:  

Mesh:

Year:  2003        PMID: 12509768     DOI: 10.1038/nrc972

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  6 in total

Review 1.  Immunotherapy for lung cancer: for whom the bell tolls?

Authors:  Pedro Madureira; Ramon Andrade de Mello; Alessandro de Vasconcelos; Yan Zhang
Journal:  Tumour Biol       Date:  2015-03-04

2.  Molecular recognition of small-cell lung cancer cells using aptamers.

Authors:  Hui William Chen; Colin D Medley; Kwame Sefah; Dihua Shangguan; Zhiwen Tang; Ling Meng; Josh E Smith; Weihong Tan
Journal:  ChemMedChem       Date:  2008-06       Impact factor: 3.466

3.  The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer.

Authors:  Olga Kagna; Anna Solomonov; Zohar Keidar; Rachel Bar-Shalom; Oren Fruchter; Mordechai Yigla; Ora Israel; Luda Guralnik
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-05       Impact factor: 9.236

4.  The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma.

Authors:  Jau-Chung Hwang; Wen-Wei Sung; Hung-Pin Tu; Kun-Chou Hsieh; Chung-Min Yeh; Chih-Jung Chen; Hui-Chun Tai; Chao-Tien Hsu; Grace S Shieh; Jan-Gowth Chang; Kun-Tu Yeh; Ta-Chih Liu
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

5.  Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer.

Authors:  Meiling Sheng; Zhaohui Dong; Yanping Xie
Journal:  Onco Targets Ther       Date:  2018-11-14       Impact factor: 4.147

6.  Blood Serum Calorimetry Indicates the Chemotherapeutic Efficacy in Lung Cancer Treatment.

Authors:  Karolina Kędra-Królik; Izabela Chmielewska; Anna Michnik; Piotr Zarzycki
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.